Inhibitory Effect of Silodosin, Tamsulosinand Terazosin in Phenylephrine Induced-Prostate Smooth Muscle Contraction (a Comparative in vitro Study)
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2018, Vol 6, Issue 4
Abstract
Objective: This in vitro study aims to compare the inhibitory effect of those α-blocker to the phenylephrine inducedprostate smooth muscle contraction. Research Method: Twenty eight eligible BPH patients were randomly allocated to 4 groups which are one control group (without α-blocker therapy) and 3 intervention groups treated with silodosin, tamsulosinand terazosine for 7 days prior to TURP surgery. The prostate tissue samples were taken during TURP surgery. This sample prepared on organ bath containing thyrod liquid and further induced with phenilephrin at dose 10-4μg/ml to measure its contraction. A oneway anova analysis was performed to investigate the significant difference among groups. Result: The mean contraction result in control, silodosin, tamsulosinand terazosin groups were 7,798mV, 1,718mV, 3,416mV, and 5,956 mV respectively (Table 1). There was a significant difference contraction value among 4 groups(p=0,000). The silodosin treatment group had the lowest mean contraction value against the controls compared with the tamsulosin and terazosin groups. Conclusion: Silodosin has the strongest inhibitory effect in phenylephrineinduced prostate smooth muscle contraction in the invitro study. BPH is a chronic progressive disease associated with lower urinary tract symptoms (LUTS) which its prevalence increases with ageand reduces the quality of life in elderly male [1,2]. Treatment for BPH aims to relieve two types of urinary tract obstruction: mechanical urinary tract obstruction caused by tissue compression due to an enlarged prostateand functional urinary tract obstruction caused by constriction of the urinary tract and prostatic smooth muscle via sympathetic α1 adrenoceptors (α1-AR). As a result, α1-AR antagonists are widely recognized as the firstline pharmacotherapy for BPH treatment [3]. Several α1-AR antagonists with its difference of selectivity are available for treatment of this disease, including silodosin, tamsulosin and terazosin. Many studies showed that those α-blocker seem to have similar efficacy in improving symptoms and urinary flow rates [4]. The high selectivity of the α1-adrenergic receptor antagonist has great efficacy and is associated with minimal side effect on cardiovascular system. Based on study that was conducted on hamsters, silodosin has a very high selectivity upto 38 times compared with tamsulosin. Another study on invivo animal test subject that compared silodosin, tamsulosin, and prazosin concluded that silodosin showed the highest selectivity compared with tamsulosin and prasozin [5]. Previous invitro study has shown that long term treatment of α- adrenergic receptor antagonists (tamsulosin 0,4mg once daily) in BPH patient can increase phenylephrineinduced prostate smooth muscle contraction [6]. This is probably due to a supersensitization mechanism in long term treatment. It is not yet clear, however, whether the use of adrenergic receptor antagonists in BPH in a short period of time can affect the contraction of smooth prostate smooth muscle.On short term crossover study comparing several types of alpha blockers, showed that 7 days treatment of alpha blocker was sufficient to determine its effectiveness and efficacy. Clinical research also suggests that different types of alpha blockers having different selectivity and affinityhave similar effectiveness on improving symptoms of IPSS and urinary outflow on BPH patient [4]. The differences in selectivity and affinity from each alpha blocker allegedly to have different effects on the prostate smooth muscle contractility. Therefore, research that compare the inhibitory effect of several alpha blocker against prostate smooth muscle contraction is needed.
Authors and Affiliations
Basuki B Purnomo, Ryan Akhmad AS, Besut Daryanto, Setyawati Soeharto
Keywords
Related Articles
- EP ID EP592379
- DOI 10.26717/BJSTR.2018.06.001401
- Views 157
- Downloads 0
Assessing Changes in Cognitive Function and Quality of Life associated with Exercise in Individuals with Parkinson’s Disease and their Caregivers
The purpose of this study was to examine the effects of a community-based, multi-modal exercise program on cognitive functioning and quality of life in individuals with Parkinson’s disease and their caregivers. Assessmen...
The Master Code of Biology: from Prions and Prions-like Invariants to the Self-assembly Thesis
For more than 25 years, we have been looking for biomathematical laws controlling and structuring DNA, genes, proteins, chromosomes and genomes [1,2]. In 1997 we discovered a simple numerical law based solely on atomic m...
Prion Paradigm: Understanding Neurodegenerative Disorders
The concept of a protein that could work as an “infecting particle” was a revolutionary idea in Biology and Medicine and, as other paradigms when they arise, took time to be accepted by the scientific community . The int...
Potential Parameters in Assessment of Testicular Toxicity
Testicular toxicity accounts for about 50 % of infertility cases in men. Though, there are several approaches to detect the testicular toxicity, the histopathological study of alterations occurred in the seminiferous tub...
Adenotonsillectomy in Children with Recurrent Acute Tonsillitis: Review and Implications for Practice Adenotonsillectomy in Recurrent Acute Tonsillitis
This paper aims at defining the therapeutic role of (adeno)tonsillectomy in children affected by recurrent acute tonsillitis (RAT), and at drawing some practical implications based on the current evidence. A literature s...